Intellicheck INC
identification authentication solutions
Based in NY
🤖
AI Overview
With $290K in lobbying spend across 10 quarterly filings, Intellicheck INC is an active lobbying client. Their lobbying covers 7 issue areas. Active from 2018 to 2020.
$290K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $130K |
| 2019 | $120K |
| 2020 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Immigration, Homeland Security, Defense, Financial, Budget/Appropriations and 2 more
- •Issues and polices related to identification authentication at Immigration and Customs Enforcement.
- •Facility security, border access and automated secure entry systems at the Department of Homeland Security (DHS) and DHS Agencies, including: Immigration and Customs Enforcement, Federal Protective Se
- •Issues and polices related to Department of Defense facility security and automated secure entry systems.
- •Issues related to reducing financial and retail identity fraud.
- •Issues related to identification authentication systems and polices; facility security; and automated secure entry systems.
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Follow the Money
Tracking lobbying dollars through the financial system.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.